The clinical response rate (CR and PR ration) of patients with unresectable advanced HCC and portal vein tumor thrombosis to the combination therapy of IFN-α and hepatic arterial infusion of 5-fluorouracil (5-FU) is about 50% [6]. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.